Your browser doesn't support javascript.
loading
Prognostic impact of low allelic ratio FLT3-ITD and NPM1 mutation in acute myeloid leukemia.
Sakaguchi, Masahiro; Yamaguchi, Hiroki; Najima, Yuho; Usuki, Kensuke; Ueki, Toshimitsu; Oh, Iekuni; Mori, Sinichiro; Kawata, Eri; Uoshima, Nobuhiko; Kobayashi, Yutaka; Kako, Shinichi; Tajika, Kenji; Gomi, Seiji; Shono, Katsuhiro; Kayamori, Kensuke; Hagihara, Masao; Kanda, Junya; Uchiyama, Hitoji; Kuroda, Junya; Uchida, Naoyuki; Kubota, Yasushi; Kimura, Shinya; Kurosawa, Saiko; Nakajima, Nana; Marumo, Atsushi; Omori, Ikuko; Fujiwara, Yusuke; Yui, Shunsuke; Wakita, Satoshi; Arai, Kunihito; Kitano, Tomoaki; Kakihana, Kazuhiko; Kanda, Yoshinobu; Ohashi, Kazuteru; Fukuda, Takahiro; Inokuchi, Koiti.
Afiliação
  • Sakaguchi M; Department of Hematology, Nippon Medical School, Tokyo, Japan.
  • Yamaguchi H; Department of Hematology, Nippon Medical School, Tokyo, Japan.
  • Najima Y; Division of Hematology, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan.
  • Usuki K; Department of Hematology, NTT Medical Center Tokyo, Tokyo, Japan.
  • Ueki T; Department of Hematology, Nagano Red Cross Hospital, Nagano, Japan.
  • Oh I; Division of Hematology, Department of Medicine, Jichi Medical University, Tochigi, Japan.
  • Mori S; Hemato-Oncology Department, St Luke's International Hospital, Tokyo, Japan.
  • Kawata E; Department of Hematology, Japanese Red Cross Kyoto Daini Hospital, Kyoto, Japan.
  • Uoshima N; Department of Hematology, Japanese Red Cross Kyoto Daini Hospital, Kyoto, Japan.
  • Kobayashi Y; Department of Hematology, Japanese Red Cross Kyoto Daini Hospital, Kyoto, Japan.
  • Kako S; Division of Hematology, Jichi Medical University Saitama Medical Center, Saitama, Japan.
  • Tajika K; Department of Hematology, Yokohama Minami Kyousai Hospital, Kanagawa, Japan.
  • Gomi S; Department of Hematology, Yokohama Minami Kyousai Hospital, Kanagawa, Japan.
  • Shono K; Department of Hematology, Chiba Aoba Municipal Hospital, Chiba, Japan.
  • Kayamori K; Department of Hematology, Chiba University Hospital, Chiba, Japan.
  • Hagihara M; Department of Hematology, Eiju General Hopital, Tokyo, Japan.
  • Kanda J; Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Uchiyama H; Department of Hematology, Japanese Red Cross Kyoto Daiichi Hospital, Kyoto, Japan.
  • Kuroda J; Division of Hematology and Oncology, Kyoto Prefectural University of Medicine, Kyoto, Japan.
  • Uchida N; Department of Hematology, Federation of National Public Service Personnel Mutual Aid Associations, Toranomon Hospital, Tokyo, Japan.
  • Kubota Y; Division of Hematology, Respiratory Medicine and Oncology, Department of Internal Medicine, Faculty of Medicine, Saga University, Saga, Japan; and.
  • Kimura S; Division of Hematology, Respiratory Medicine and Oncology, Department of Internal Medicine, Faculty of Medicine, Saga University, Saga, Japan; and.
  • Kurosawa S; Department of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan.
  • Nakajima N; Department of Hematology, Nippon Medical School, Tokyo, Japan.
  • Marumo A; Department of Hematology, Nippon Medical School, Tokyo, Japan.
  • Omori I; Department of Hematology, Nippon Medical School, Tokyo, Japan.
  • Fujiwara Y; Department of Hematology, Nippon Medical School, Tokyo, Japan.
  • Yui S; Department of Hematology, Nippon Medical School, Tokyo, Japan.
  • Wakita S; Department of Hematology, Nippon Medical School, Tokyo, Japan.
  • Arai K; Department of Hematology, Nippon Medical School, Tokyo, Japan.
  • Kitano T; Department of Hematology, Nippon Medical School, Tokyo, Japan.
  • Kakihana K; Division of Hematology, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan.
  • Kanda Y; Division of Hematology, Department of Medicine, Jichi Medical University, Tochigi, Japan.
  • Ohashi K; Division of Hematology, Jichi Medical University Saitama Medical Center, Saitama, Japan.
  • Fukuda T; Division of Hematology, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan.
  • Inokuchi K; Department of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan.
Blood Adv ; 2(20): 2744-2754, 2018 10 23.
Article em En | MEDLINE | ID: mdl-30341082
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Leucemia Base de dados: MEDLINE Assunto principal: Proteínas Nucleares / Leucemia Mieloide Aguda / Tirosina Quinase 3 Semelhante a fms Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Blood Adv Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Japão
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Leucemia Base de dados: MEDLINE Assunto principal: Proteínas Nucleares / Leucemia Mieloide Aguda / Tirosina Quinase 3 Semelhante a fms Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Blood Adv Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Japão